candesartan 中文意思是什麼
candesartan
解釋
坎地沙坦-
Evaluation on efficacy and safety of candesartan ciexetil in treatment of mild - to - moderate essential hypertension
國產坎地沙坦酯膠囊治療輕中度原發性高血壓療效和安全性的評價 -
Candesartan is a highly selective angiotensin type receptor blocker, mainly used in the treatment of hypertension and heart failure
摘要坎地沙坦是一個高選擇性血管緊張肽受體拮抗藥，主要用於高血壓和心力衰竭的治療。 -
These findings suggest that candesartan has dosage - dependent, anti - inflammatory effects that are mediated by suppression of nf - b actiation and chemokine expression
這些研究表明，坎地沙坦是劑量依賴性、抗炎作用是通過抑制nf - b的活性和趨化因子表達介導的。 -
A large number of clinical trials showed that candesartan could reduce the cardiovascular mortality for heart failure and hospitalization for worsening heart failure
大量臨床研究結果表明坎地沙坦可降低心力衰竭病人心血管死亡率和因心力衰竭加重的住院率。 -
These findings suggest that candesartan has dosage - dependent, anti - inflammatory effects that are mediated by suppression of nf - b activation and chemokine expression
這些研究表明，坎地沙坦是劑量依賴性、抗炎作用是通過抑制nf - b的活性和趨化因子表達介導的。 -
Conclusions : the addition of spironolactone to candesartan has significant beneficial effects on lv reverse remodeling in patients with mild - to - moderate chronic systolic hf
結論：坎地沙坦聯合螺內酯治療對輕中度慢性收縮性心力衰竭患者的lv逆重構有明顯益處。 -
This study examined the effects of long - term ( 14 mo ) administration of ultrahigh dosages of the angiotensin receptor blocker candesartan on the progression of renal injury in spontaneously hypertensie rats ( shr )
該研究調查了超高劑量的血管緊張素受體阻滯劑坎地沙坦對自發性高血壓大鼠的腎損傷進展的長期效應（ 14個月） 。 -
This study examined the effects of long - term ( 14 mo ) administration of ultrahigh dosages of the angiotensin receptor blocker candesartan on the progression of renal injury in spontaneously hypertensive rats ( shr )
該研究調查了超高劑量的血管緊張素受體阻滯劑坎地沙坦對自發性高血壓大鼠的腎損傷進展的長期效應（ 14個月） 。 -
Methods : fifty - one systolic hf patients with left ventricular ejection fraction ( lvef ) < 40 % were randomly assigned to receive 1 - year treatment of candesartan and spironolactone ( combination group ) or candesartan and placebo ( control group )
方法： 51名左室射血分數（ lvef ） < 40 %的收縮性心力衰竭患者隨機分配到接受坎地沙坦和螺內酯治療1年（聯合治療組）或坎地沙坦和安慰劑治療（對照組） 。
分享友人